title: Altered mRNA editing and expression of ionotropic glutamate receptors after kainic acid exposure in cyclooxygenase-2 deficient mice.
abstract: Kainic acid (KA) binds to the AMPA/KA receptors and induces seizures that result in inflammation, oxidative damage and neuronal death. We previously showed that cyclooxygenase-2 deficient (COX-2(-/-)) mice are more vulnerable to KA-induced excitotoxicity. Here, we investigated whether the increased susceptibility of COX-2(-/-) mice to KA is associated with altered mRNA expression and editing of glutamate receptors. The expression of AMPA GluR2, GluR3 and KA GluR6 was increased in vehicle-injected COX-2(-/-) mice compared to wild type (WT) mice in hippocampus and cortex, whereas gene expression of NMDA receptors was decreased. KA treatment decreased the expression of AMPA, KA and NMDA receptors in the hippocampus, with a significant effect in COX-2(-/-) mice. Furthermore, we analyzed RNA editing levels and found that the level of GluR3 R/G editing site was selectively increased in the hippocampus and decreased in the cortex in COX-2(-/-) compared with WT mice. After KA, GluR4 R/G editing site, flip form, was increased in the hippocampus of COX-2(-/-) mice. Treatment of WT mice with the COX-2 inhibitor celecoxib for two weeks decreased the expression of AMPA/KA and NMDAR subunits after KA, as observed in COX-2(-/-) mice. After KA exposure, COX-2(-/-) mice showed increased mRNA expression of markers of inflammation and oxidative stress, such as cytokines (TNF-α, IL-1β and IL-6), inducible nitric oxide synthase (iNOS), microglia (CD11b) and astrocyte (GFAP). Thus, COX-2 gene deletion can exacerbate the inflammatory response to KA. We suggest that COX-2 plays a role in attenuating glutamate excitotoxicity by modulating RNA editing of AMPA/KA and mRNA expression of all ionotropic glutamate receptor subunits and, in turn, neuronal excitability. These changes may contribute to the increased vulnerability of COX-2(-/-) mice to KA. The overstimulation of glutamate receptors as a consequence of COX-2 gene deletion suggests a functional coupling between COX-2 and the glutamatergic system.
authors: Molecular Neuroscience Unit, Brain Physiology and Metabolism Section, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, United States of America.
authors: Luca
authors: L
authors: Caracciolo
authors: Alessandro
authors: A
authors: Barbon
authors: Sara
authors: S
authors: Palumbo
authors: Cristina
authors: C
authors: Mora
authors: Christopher D
authors: CD
authors: Toscano
authors: Francesca
authors: F
authors: Bosetti
authors: Sergio
authors: S
authors: Barlati
references: Science. 1994 Dec 9;266(5191):1709-13
references: 7992055
references: Genome Biol. 2007;8(1):R14
references: 17266762
references: Neuron. 2002 Jul 3;35(1):17-20
references: 12123604
references: Epilepsy Res. 2000 Mar;39(1):63-71
references: 10690755
references: J Neurochem. 1994 May;62(5):2057-60
references: 7512622
references: Neuron. 1993 Mar;10(3):491-500
references: 7681676
references: Nat Neurosci. 2002 May;5(5):405-14
references: 11953750
references: Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2317-21
references: 8637870
references: Neurobiol Dis. 2004 Mar;15(2):371-9
references: 15006707
references: Brain Res. 2010 Apr 30;1328:130-8
references: 20144592
references: Neuron. 2002 May 30;34(5):759-72
references: 12062022
references: Epilepsy Behav. 2005 Dec;7 Suppl 3:S3-11
references: 16278099
references: Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):755-9
references: 7678465
references: Exp Neurol. 2007 Nov;208(1):54-62
references: 17706642
references: J Physiol. 1996 Apr 1;492 ( Pt 1):129-42
references: 8730589
references: J Cell Biol. 2002 Aug 5;158(3):541-9
references: 12163474
references: Neurobiol Aging. 1994 Mar-Apr;15(2):275-6
references: 7838311
references: Prog Brain Res. 1992;94:271-80
references: 1363145
references: J Neuroinflammation. 2008 May 19;5:17
references: 18489773
references: Pharmacol Rev. 1999 Mar;51(1):7-61
references: 10049997
references: Prostaglandins. 1997 Sep;54(3):601-24
references: 9373877
references: Neuropharmacology. 1998 Oct-Nov;37(10-11):1187-204
references: 9849657
references: J Appl Toxicol. 2001 Sep-Oct;21(5):403-7
references: 11746182
references: Brain Res Mol Brain Res. 2003 Oct 7;117(2):168-78
references: 14559151
references: Neurobiol Aging. 1989 Sep-Oct;10(5):593-602
references: 2554168
references: Subcell Biochem. 2007;42:127-41
references: 17612048
references: Neurochem Res. 1994 Dec;19(12):1557-64
references: 7877729
references: Mol Psychiatry. 2008 Jan;13(1):99-114
references: 17486105
references: Am J Alzheimers Dis Other Demen. 2005 Mar-Apr;20(2):77-85
references: 15844753
references: Cell. 1995 Nov 3;83(3):473-82
references: 8521477
references: J Biol Chem. 2005 Oct 14;280(41):35018-27
references: 16049015
references: Prog Neurobiol. 1998 Apr;54(5):581-618
references: 9550192
references: Mol Neurobiol. 2005;31(1-3):3-16
references: 15953808
references: Inflamm Res. 2000 Aug;49(8):367-92
references: 11028754
references: Recept Channels. 1995;3(1):41-9
references: 8589992
references: Neuroreport. 1998 Jul 13;9(10):2219-24
references: 9694203
references: Clin Neurosci. 1995-1996;3(6):348-59
references: 9021256
references: Neurobiol Aging. 1989 Sep-Oct;10(5):605-6; discussion 618-20
references: 2554169
references: Brain Res Bull. 2008 Mar 28;75(5):598-609
references: 18355636
references: Eur J Neurosci. 1999 Feb;11(2):604-16
references: 10051761
references: Neuron. 2002 Mar 14;33(6):849-60
references: 11906693
references: Cell. 1995 Nov 3;83(3):483-92
references: 8521478
references: Nature. 2004 Feb 26;427(6977):801
references: 14985749
references: Pharmacol Ther. 1999 Mar;81(3):163-221
references: 10334661
references: J Mol Med (Berl). 2005 Feb;83(2):110-20
references: 15624111
references: Science. 2003 Oct 3;302(5642):84-8
references: 14526074
references: Can J Neurol Sci. 1991 Aug;18(3 Suppl):394-7
references: 1657348
references: Neuron. 2003 Nov 13;40(4):763-74
references: 14622580
references: Trends Neurosci. 1988 Oct;11(10):465-9
references: 2469166
references: J Comp Neurol. 1995 May 1;355(2):296-315
references: 7608344
references: Neurochem Int. 1997 Nov;31(5):715-22
references: 9364457
references: Arch Gen Psychiatry. 2002 Jul;59(7):592-6
references: 12090811
references: J Neurochem. 2010 Jul;114(2):397-407
references: 20456005
references: J Nutr. 2000 Apr;130(4S Suppl):1007S-15S
references: 10736372
references: Eur J Neurosci. 2002 Jan;15(1):51-62
references: 11860506
references: J Biomed Sci. 1998 Nov-Dec;5(6):401-14
references: 9845843
references: J Biol Chem. 1993 Feb 5;268(4):2836-43
references: 8428958
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: Brain Res. 2002 Dec 13;957(2):330-7
references: 12445975
references: Neurobiol Dis. 2001 Jun;8(3):459-68
references: 11442354
references: J Neurosci. 1999 Dec 15;19(24):10603-10
references: 10594044
references: Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3631-6
references: 10725374
references: Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14687-92
references: 11717408
references: Neuroscience. 2009 Mar 3;159(1):358-68
references: 19154779
references: Neuron. 1988 Oct;1(8):623-34
references: 2908446
references: Int Rev Cytol. 2002;221:93-148
references: 12455747